Amy Ritter, PhD
Advertisement
Scientific Editor, BioPharm International
Articles by Amy Ritter, PhD
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Merck TROP2 ADC Meets Survival End Point in Gastroesophageal Cancer
2
The BioPharm Brief: A Matrix-Targeting ADC in Head and Neck Cancer, an RNAi Approval in Myasthenia Gravis, and AbbVie Bets on AND-Gated Bispecifics
3
Immunotherapy Alone Spares dMMR Rectal Cancer Patients the Lasting Effects of Standard Treatment, Says MSK's Andrea Cercek
4
AbbVie and DISCO Partner on AND-Gated Bispecifics Designed to Recognize Tumor-Selective Protein Pairs
5

